OriGene Logo

Customer Login

Checkout as a new customer

Creating an account has many benefits:

  • See order and shipping status
  • Track order history
  • Check out faster
Create an Account

TissueScan, Colon Cancer cDNA Array I

Be the first to review this product
SKU
HCRT501
TissueScan Colon Cancer Tissue qPCR Panel I (10) containing ten identical sets of 48 tissues covering four disease stages and normal tissues
  $2,500.00
In Stock*

Frequently Bought Together (4)

D11-18 Polink-1 HRP Polymer Detection for MOUSE and RABBIT antibodies on human tissue
18 ml
$420.00
D12-6 Polink-1 HRP Polymer Detection for MOUSE antibody on human or animal tissue (non-rodent)
6 ml
$250.00
HP205798 qSTAR qPCR primer pairs against Homo sapiens gene GAPDH 200 reactions
$150.00
MP205604 qSTAR qPCR primer pairs against Mus musculus gene Gapdh 200 reactions
$150.00
Specifications
Specifications
Product Data
TissueScan Type Cancer Specific
Array Name Colon Cancer cDNA Array I
Clinical Info
Diagnosis Category Colon Cancer
Tissue Colon
Shipping Ambient
Description TissueScan Colon Cancer Tissue qPCR Panel I (10) containing ten identical sets of 48 tissues covering four disease stages and normal tissues
Reviews
Write Review
 
 
 
 
 

Be the first to review this product

Please note:
Only reviews with images are eligible for a $20/20€ Amazon gift card.
Reviews without images are eligible for a $10/10€ Amazon gift card.
For more details about the terms and conditions, please visit the promotion page.

Review image
Documents
Resources

file-alt Citations

FXR silencing in human colon cancer by DNA methylation and KRAS signaling
Bailey, Zhan, Maru et al
Am J Physiol Gastrointest Liver Physiol (2014) 306 (1), G48-58 DOI: 10.1152/ajpgi.00234.2013
Cited by 86
AI Summary: In this study, OriGene products—including the KRAS shRNA (OriGene, catalog # TF311133) and human FXR/NR1H4 cDNA (OriGene, catalog # SC117893)—were used to manipulate gene expression in colon cancer cell lines, enabling the authors to investigate the roles of KRAS signaling and FXR silencing in colon cancer progression.
The mRNA binding proteins HuR and tristetraprolin regulate cyclooxygenase 2 expression during colon carcinogenesis
Young, Sanduja, Bemis-Standoli et al
Gastroenterology (2009) 136 (5), 1669-79 DOI: 10.1053/j.gastro.2009.01.010
Cited by 244
AI Summary: In this study, OriGene’s HuR (SC11971) and TTP (SC11972) expression plasmids were used to create inducible cell lines, enabling the authors to investigate how these RNA-binding proteins regulate COX-2 expression during colon cancer development.
FigureFigure
Showing 1-2 of 2 papers.
Powered by BizGenius
*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen complexities in the preparation of your product. International customers may expect an additional 1-2 weeks in shipping.

Related Products